Detalhe da pesquisa
1.
Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer.
Int J Mol Sci
; 24(13)2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445886
2.
CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer.
Cancer Lett
; 590: 216845, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589004
3.
Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview.
Pharmaceutics
; 14(2)2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35214121
4.
ADAM9-Responsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery in Pancreatic Cancer.
Cancers (Basel)
; 13(13)2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282781